Also found in: Thesaurus, Medical, Wikipedia.


 (nə-vîr′ə-pēn′, -pĭn)
An antiviral drug, C15H14N4O, that is a non-nucleoside reverse transcriptase inhibitor and is used in combination with other drugs for the treatment of HIV infection.

[ne- (probably shortening of non-nucleoside) + vir(us) + alteration of (diaz)epine.]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.nevirapine - a non-nucleoside reverse transcriptase inhibitor (trade name Viramune) used to treat AIDS and HIV
NNRTI, non-nucleoside reverse transcriptase inhibitor - an antiviral drug used against HIV; binds directly to reverse transcriptase and prevents RNA conversion to DNA; often used in combination with other drugs


n nevirapina
References in periodicals archive ?
Non-nucleoside inhibitors, nevirapine and efavirenz are used in combination with nucleoside analogs for the treatment of HIV and are associated with the development of a maculopapular rash, dizziness, feeling of light-headedness.
M2 PHARMA-November 18, 2015-Mylan introduces Nevirapine Extended-release Tablets in US
M2 EQUITYBITES-November 18, 2015-Mylan introduces Nevirapine Extended-release Tablets in US
2) Later is being done with purpose of linking seropositive antenatal women with ART as soon as possible in order to derive maximum benefit to prevent opportunistic infections and to provide single dose nevirapine to both mother and child to prevent vertical transmission.
The link between systemic hypersensitivity reactions and nevirapine has been well documented.
The political and practical difficulties of introducing nevirapine to Africa where HIV infection rates are high round out the last several chapters.
Women in the maternal-antiretroviral group, but not their infants, continued taking zidovudine, lamivudine and nevirapine, although after February 2005 other drugs were substituted for nevirapine in this group because of toxicity concerns.
Adding the drug nevirapine to the regimen given to newborns of women diagnosed with HIV shortly before or during labor halves the newborns' risk of contracting the virus, according to findings by a National Institutes of Health research network.
Use of nevirapine with co-trimoxazole prophylaxis in HIV-exposed, uninfected (HIV-EU) infants until 6 months of age in Zimbabwe and Uganda was safe with no immediate or long-term adverse effects, researchers on behalf of the HIV Prevention Trials Network (HPTN) 046 protocol trial report in the advance online edition of AIDS.
Recent findings from five randomised trials in the US, Ethiopia, India, Uganda and Malawi show that extended use of nevirapine or zidovudine plus nevirapine in breastfeeding infants can reduce the risks of HIV transmission through breastmilk by 71%.
Washington, Mar 3 (ANI): In a new study, scientists found that giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks.
Several regimens have been tested for prevention of parent-to-child transmission (PPTCT), including nevirapine (NVP) given as a single dose to the mother at the time of delivery followed by a single dose to the infant within 72 h (Sd-NVP) (2).